Small non-coding RNA or microRNA (miRNA) are critical regulators of eukaryotic cells.
Dysregulation of miRNA expression and function has been linked to a variety of diseases …

Pancreatic cancer is the third leading cause of cancer-related death in the United States.
Pancreatic ductal adenocarcinoma (PDAC) is the major form of pancreatic cancer with the …

Pancreatic ductal adenocarcinoma (PDAC) is a highly aggressive cancer with a poor
prognosis, primarily due to a late diagnosis. Recent studies have focused on identifying non …

With the lack of specific signs and symptoms, pancreatic ductal adenocarcinoma (PDAC) is
often diagnosed at late metastatic stages, resulting in poor survival outcomes. Among …

Therapy for pancreatic ductal adenocarcinoma remains challenging, and the chances of a
complete cure are very limited. As in other types of cancer, the expression and role of …

Undifferentiated carcinoma with osteoclast-like giant cells (UCOGC) of the pancreas
represents a rare subtype of pancreatic ductal adenocarcinoma (PDAC). Despite a distinct …

Preneoplastic high-risk lesions in the pancreas need to be differentiated from low-risk
lesions warranting surveillance and eventually surgical intervention. Imaging is used so far; …

Pancreatic ductal adenocarcinoma (PDAC) is one of the most aggressive and lethal forms of
cancer. The symptoms appear in advanced stages, and diagnostic and prognostic tests for …

Background: Pancreatic ductal adenocarcinoma (PDAC) is one of the most aggressive and
lethal malignancy with poor prognosis. To improve patient outcomes, it is necessary to gain …

The causal networks are important for understanding the signaling alterations in diseases.
To reveal the network pathways affected in epithelial-mesenchymal transition (EMT) and …